SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001831283-22-000012
Filing Date
2022-03-30
Accepted
2022-03-30 16:55:10
Documents
14
Period of Report
2022-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lian-20220330.htm   iXBRL 8-K 36617
2 EX-99.1 q42021earningspressrelease.htm EX-99.1 103051
6 image_0a.jpg GRAPHIC 51987
  Complete submission text file 0001831283-22-000012.txt   368210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lian-20220330.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lian-20220330_lab.xml EX-101.LAB 25948
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lian-20220330_pre.xml EX-101.PRE 13679
8 EXTRACTED XBRL INSTANCE DOCUMENT lian-20220330_htm.xml XML 12306
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40947 | Film No.: 22787290
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences